Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-5 of 5 for your search:
Drug:
rasburicase
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Phase:
Phase IV
Type:
Supportive care
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
RASALL
, NCT00186940
2.
Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
Over 15
Sponsor:
Other
Protocol IDs:
GMALL08
, NCT00199043
3.
Evaluation of Rasburicase for Hyperuricemia Associated With Tumor Lysis Syndrome
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
No age specified
Sponsor:
Other
Protocol IDs:
RASBUR
, NCT00247767
4.
Rasburicase in Patients at Risk for Tumor Lysis Syndrome
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2006-0918
, NCT00628628
5.
Pilot Study of Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Other Diseases Undergoing Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Supportive care, Treatment
Status:
Active
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
MGH-07-071
, 07-071, DFCI-07-071, NCT00513474
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute